Successful treatment of cutaneous Acanthamoeba castellanii infection with miltefosine in a patient with chronic lymphocytic leukaemia on ibrutinib

被引:3
作者
Teh, Joanne S. K. [1 ,2 ]
Tam, Patrick C. K. [1 ,3 ]
Badenoch, Paul R. [3 ,4 ]
Adamson, Penelope J. [1 ,2 ,3 ]
Brennan, Catriona [2 ,5 ]
Marshman, Gillian [6 ]
Gordon, David L. [1 ,2 ,3 ]
机构
[1] Flinders Med Ctr, Dept Microbiol & Infect Dis, Flinders Dr, Bedford Pk, SA 5042, Australia
[2] Flinders Med Ctr, SA Pathol, Flinders Dr, Bedford Pk, SA 5042, Australia
[3] Flinders Univ S Australia, Coll Med & Publ Hlth, Sturt Rd, Bedford Pk, SA 5042, Australia
[4] Flinders Med Ctr, Dept Ophthalmol, Flinders Dr, Bedford Pk, SA 5042, Australia
[5] Flinders Med Ctr, Dept Anat Pathol, Flinders Dr, Bedford Pk, SA 5042, Australia
[6] Flinders Med Ctr, Dept Dermatol, Flinders Dr, Bedford Pk, SA 5042, Australia
关键词
D O I
10.1093/jac/dkab397
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
[No abstract available]
引用
收藏
页码:539 / 541
页数:3
相关论文
共 12 条
[1]   Investigation of the in vitro cysticidal activity of miltefosine against Acanthamoeba spp. [J].
Chao M. ;
Thongseesuksai T. ;
Boonmars T. ;
Laummaunwai P. .
Journal of Parasitic Diseases, 2020, 44 (2) :491-495
[2]  
Cope JR, 2013, MMWR-MORBID MORTAL W, V62, P666
[3]   Fulminant Acanthamoeba castellanii Encephalitis in an Ibrutinib-Treated Patient [J].
Crothers, Jessica W. ;
Hsu, Liangge ;
Marty, Francisco M. .
OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (02)
[4]   Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis [J].
Dorlo, Thomas P. C. ;
Balasegaram, Manica ;
Beijnen, Jos H. ;
de Vries, Peter J. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (11) :2576-2597
[5]   Cutaneous acanthamebiasis infection in immunocompetent and immunocompromised patients [J].
Galarza, Carlos ;
Ramos, Willy ;
Gutierrez, Ericson L. ;
Ronceros, Gerardo ;
Teran, Maria ;
Uribe, Martha ;
Navincopa, Marcos ;
Ortega-Loayza, Alex G. .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2009, 48 (12) :1324-1329
[6]   Antimicrobial susceptibility of 19 Australian corneal isolates of Acanthamoeba [J].
Lim, L ;
Coster, DJ ;
Badenoch, PR .
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2000, 28 (02) :119-124
[7]   Acanthamoeba spp. as agents of disease in humans [J].
Marciano-Cabral, F ;
Cabral, G .
CLINICAL MICROBIOLOGY REVIEWS, 2003, 16 (02) :273-+
[8]   Evaluation of in vitro activity of five antimicrobial agents on Acanthamoeba isolates and their toxicity on human corneal epithelium [J].
Megha, Kirti ;
Sharma, Megha ;
Sharma, Chayan ;
Gupta, Amit ;
Sehgal, Rakesh ;
Khurana, Sumeeta .
EYE, 2022, 36 (10) :1911-1917
[9]  
Parmar Sapna, 2014, P T, V39, P483
[10]   Use of subgenic 18S ribosomal DNA PCR and sequencing for genus and genotype identification of acanthamoebae from humans with keratitis and from sewage sludge [J].
Schroeder, JM ;
Booton, GC ;
Hay, J ;
Niszl, IA ;
Seal, DV ;
Markus, MB ;
Fuerst, PA ;
Byers, TJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (05) :1903-1911